Text Size
Trial record 1 of 1 for:    yoga epilepsy
Previous Study | Return to List | Next Study

Yoga for Patients With Epilepsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Beth Israel Deaconess Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00179452
First received: September 13, 2005
Last updated: December 27, 2007
Last verified: December 2007
History of Changes
  Purpose

To establish the safety and feasibility of having patients with epilepsy perform yoga.


Condition Intervention
Epilepsy
 Behavioral: Yoga

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Is Yoga Safe for Patients With Epilepsy?

Resource links provided by NLM:

MedlinePlus related topics: Epilepsy
U.S. FDA Resources

Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Improvement in quality of life assessments.
  • Improvement in mood.

Secondary Outcome Measures:
  • Improvement in seizure control.

Estimated Enrollment: 20
Study Start Date: October 2003
Estimated Study Completion Date: October 2004
Detailed Description:

Subjects will keep logs of seizure frequency prior to, during, and following training in a yoga regimen. Instruction in the yoga regimen will occur at BIDMC, and home practice following classroom instruction will occur as part of the study. Side effects, changes in seizure frequency, and quality of life assessments will be performed.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Must be able to give full informed consent.
  2. Must have one or more of the following seizure types: simple partial, complex partial, or secondarily generalized.
  3. Age 18-64.
  4. Must have 4-20 during the baseline phase.
  5. Must have medical clearance from their primary care giver sufficient to allow for participation in yoga exercises.
  6. Must be stable enough to allow for all anticonvulsant levels to remain constant for the duration of the study.

Exclusion Criteria:

  1. Having primary generalized epilepsy or atonic seizures.
  2. Having a history of status epilepticus in the past two years.
  3. Any medical problem that would preclude participation in a yoga class.
  4. Nonepileptic or psychogenic seizures.
  5. Pregnancy.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179452

Contacts
Contact: Kaarkuzhali Krishnamurthy, MD 617-667-5387 bkrishna@bidmc.harvard.edu
Contact: Robyn Stiles 617-667-5387 rstiles@bidmc.harvard.edu

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center Recruiting
Boston, Massachusetts, United States, 02215
Contact: Kaarkuzhali B Krishanmurthy, MD     617-667-4088     bkrishna@bidmc.harvard.edu    
Contact: Robyn Stiles     617-667-5387     rstiles@bidmc.harvard.edu    
Sub-Investigator: Jennifer Johnston            
Sub-Investigator: Ann Wohlhueter            
Sub-Investigator: Jeff Dusek, PhD            
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Kaarkuzhali Krishanmurthy, MD Beth Israel Deaconess Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00179452     History of Changes
Other Study ID Numbers: 2003P-000337
Study First Received: September 13, 2005
Last Updated: December 27, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Beth Israel Deaconess Medical Center:
epilepsy, yoga

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 16, 2013